A61K 35/02
From inanimate materials
Official title: from inanimate materials (carbon A61K33/44)
A61K35/02 (From inanimate materials) appears on 330 US grants and 512 published applications in this corpus.
Search patents in A61K- Granted patents
- 330
- Published applications
- 512
- Assignees
- 269
- Inventors
- 798
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 8 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 2 |
| 2003 | 4 | 6 |
| 2004 | 3 | 4 |
| 2005 | 5 | 14 |
| 2006 | 1 | 13 |
| 2007 | 3 | 10 |
| 2008 | 1 | 11 |
| 2009 | 3 | 17 |
| 2010 | 3 | 21 |
| 2011 | 2 | 9 |
| 2012 | 9 | 12 |
| 2013 | 3 | 17 |
| 2014 | 13 | 31 |
| 2015 | 15 | 22 |
| 2016 | 20 | 30 |
| 2017 | 9 | 24 |
| 2018 | 23 | 23 |
| 2019 | 10 | 32 |
| 2020 | 20 | 34 |
| 2021 | 20 | 44 |
| 2022 | 23 | 34 |
| 2023 | 15 | 25 |
| 2024 | 23 | 36 |
| 2025 | 25 | 26 |
| 2026 | 5 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Heterocyclic inhibitors of Rho GTPases for the treatment of disease7 Jul 2026US 12,673,960 B2MBQ Pharma
- Recombinant interferon with changed spatial configuration26 May 2026US 12,636,347 B2
- Methods for treatment of psoriasis with an anti-oxLDL antibody5 May 2026US 12,616,749 B2Abcentra, LLC
- PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer21 Apr 2026US 12,606,616 B2Cardiff Oncology, Inc.
- Testosterone enhancing compositions and methods17 Feb 2026US 12,551,502 B1Direct Digital, LLC
- Heterocyclic inhibitors of rho gtpases for the treatment of disease8 Oct 2026US 2026/0308180 A1
- Muscle mass increasing agent and endurance improving agent20 Aug 2026US 2026/0240906 A1Kohaku Bio Technology Co., Ltd.
- Transdermal permeation enhancing composition and application thereof in timolol preparation13 Aug 2026US 2026/0232685 A1Wuhan Conform Pharmaceutical Co., Ltd.
- Antibody against blood cancer25 Jun 2026US 2026/0174798 A1The University of Osaka
- Fatty acid compositions18 Jun 2026US 2026/0165995 A1Fera Diagnostics and Biologicals Corp.
Most cited
By later US patents
- Composition and method for treatment of psoriasis112US 5,990,100 APanda Pharmaceuticals, L.L.C. · 1999
- Tar gel formulation107US 4,102,995 AWestwood Pharmaceuticals, Inc. · 1978
- Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood62US 5,622,848 AMedical Discoveries, Inc. · 1997
- Topical liquid or ointment57US 4,379,143 APQ Corporation · 1983
- Vitamin/mineral composition52US 5,405,613 ACreative Nutrition Canada Corp. · 1995